Express Pharma
Home  »  Market  »  Healthcare industry reported 85 deals worth $30 billion in Feb 2021

Healthcare industry reported 85 deals worth $30 billion in Feb 2021

Three big ticket deals contribute 74 per cent of total deal value in Feb 2021

0 563
Read Article

In February 2021, the healthcare industry reported 85 deals worth $30 billion as compared to last 12-month average (February 2020 to January 2021) of 88 deals worth $17.3 billion.

ICON, a provider of outsourced development services to the biotechnology, pharmaceutical and medical device industries is set to acquire PRA Health Sciences, a contract research organisation engaged in providing outsourced clinical development and data solution services for approximately $12 billion; Jazz Pharmaceuticals, a biopharma company is set to acquire GW Pharmaceuticals, also a biopharma company for $7.2 billion and Horizon Therapeutics, a biopharma company is set to acquire Viela Bio, a biotech company specialised in discovery, development and commercialisation of novel treatments for autoimmune and severe inflammatory diseases for $3 billion are the three major deals which contributed 74 per cent of the total deal value in February 2021.

Deal Date Acquirer (s) Target Deal Value
($ m)
24-Feb-21 ICON Plc (Ireland) PRA Health Sciences Inc (US) 12,000.0
3-Feb-21 Jazz Pharmaceuticals Plc(Ireland) GW Pharmaceuticals Plc (United Kingdom) 7,200.0
1-Feb-21 Horizon Therapeutics Plc(Ireland) Viela Bio Inc (US) 3,050.0
25-Feb-21 Merck & Co Inc (US) Pandion Therapeutics Inc (US) 1,850.0
26-Feb-21 Teijin Pharma Ltd (Japan) Portfolio of Diabetes Products (Japan) 1,252.8

VC investments decreased by 34.7 per cent in Feb 2021, compared to Jan 2021

The healthcare industry reported 88 venture capital (VC) deals worth $3.2billion in February 2021, compared to the last 12-month average (February 2020 to January 2021) of 125 deals worth $3.5 billion.

Centessa Pharmaceuticals, a biopharma company raising $250 million in series A round of financing; Clover Biopharmaceuticals, a clinical-stage biotechnology company raising $230 million in series C  round of financing to support the continued development and expansion of its pipeline of protein-based vaccines and biologic cancer therapies; Vividion Therapeutics, a biotech company raising $135 million in series C round of financing to fuel broad pipeline of precision oncology and immunology programs are the major VC deals reported in February 2021.

Deal Date Acquirer (s) Target Deal Value
($ m)
16-Feb-21 Wellington Management Company LLP; General Atlantic LLC; EcoR1 Capital LLC; Venrock Healthcare Capital Partners LP; Undisclosed Firm; Boxer Capital LLC; Cormorant Asset Management LLC; Franklin Templeton Investments; BVF Partners LP; Samsara BioCapital LLC; Janus Henderson Investors; LifeSci Venture Partners; T Rowe Price Associates Inc; Vida Ventures LLC; Logos Global Management LLC Centessa Pharmaceuticals Ltd (United Kingdom) 250.0
23-Feb-21 Temasek Holdings (Private) Ltd; Orbimed Advisors LLC; Delos Capital LLC; Oceanpine Capital; GL Ventures Clover Biopharmaceuticals (China) 230.0
24-Feb-21 BlackRock Inc; Nextech Invest Ltd; RA Capital Management LP; ARCH Venture Partners LP; Versant Venture Management LLC; Driehaus Capital Management LLC; Boxer Capital LLC; Casdin Capital LLC; BVF Partners LP; Acuta Capital Partners, LLC; Mubadala Capital; T Rowe Price Associates Inc; Surveyor Capital Ltd; SoftBank Investment Advisers; Logos Global Management LLC; Woodline Partners; Avoro Capital Advisors LLC Vividion Therapeutics Inc (US) 135.0
24-Feb-21 OrbiMed Asia Partners; Oceanpine Capital Yisheng Biopharma Co Ltd (China) 130.0
10-Feb-21 Franklin Resources Inc; Viking Global Investors LP; RA Capital Management LP; Atlas Venture Inc; Canaan Partners; Perceptive Advisors LLC; Boxer Capital LLC; BVF Partners LP; Janus Henderson Investors; T Rowe Price Associates Inc; Access Biotechnology Day One Biopharmaceuticals Inc (US) 130.0

Source: GlobalData

Leave A Reply

Your email address will not be published.

Virtual Conference

PHARMA PACKAGING AND LABELLING CONCLAVE

Attend India's Largest Pharma Packaging & Labelling Conclave & Attend LIVE sessions by Industry experts.
REGISTER NOW
close-link
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Attend India's Largest Pharma Packaging & Labelling Conclave
Register Now
close-image